SNY - Alto Neuroscience schizophrenia treatment shows good phase 1 results
2024-04-23 13:21:30 ET
More on Alto Neuroscience
- Alto Neuroscience: Potential First-In-Class Approach To Targeting CNS Disorders
- Stifel, Baird, Jefferies bullish on Alto Neuroscience, cite upcoming data
- Alto Neuroscience stock rallies 35% following upsized IPO
- Historical earnings data for Alto Neuroscience
- Financial information for Alto Neuroscience